FDA vaccine studies censored by Trump admin after finding benefits of shots
FDA has suppressed studies on COVID-19 vaccines and Shingrix, a shingles vaccine.
Signal weather
Rising
Momentum is building quickly, so this card is a good early entry point into the topic.
Despite Health Secretary Robert F. Kennedy's pledge to provide "radical transparency," the agencies under his control continue to suppress scientific research that conflicts with his anti-vaccine agenda. On Tuesday, The New York Times reported confirmation from the Department of Health and Human Services that the Food and Drug Administration had blocked the publication of studies showing the safety and efficacy of vaccines against COVID-19 and shingles. The revelation follows a report from The Washington Post last month that the Centers for Disease Control and Prevention scrapped a scientifically vetted study previously scheduled for publication that found COVID-19 vaccines sharply cut the risk of emergency care and hospitalization among healthy adults. The study was ultimately rejected by Kennedy's acting CDC director, who claimed to have concerns about the study's methodology. Similarly at the FDA, two studies on COVID-19 vaccines by agency scientists were accepted for publication at medical journals, according to the Times. But unnamed FDA officials directed the agency scientists to withdraw the studies. While a preliminary abstract of one of the studies presented at a conference last fall remains online, the Times obtained a copy of the full manuscript, the conclusion of which reads, "Given the available evidence, FDA continues to conclude the benefits of vaccination outweigh the risks."Read full article Comments
Stay on the signal
Follow FDA vaccine studies censored by Trump admin after finding benefits of shots
Follow this story beyond a single article: new follow-ups, adjacent sources, and the evolving storyline.
Story map
Understand this topic fast
A quick entry into the story: why it matters now, who is involved, and where to go next for context.
Why it matters now
Topic constellation
Open the live map for this story
See which entities, story threads, sources, and follow-up articles shape this story right now.
Click nodes to continue
Entity pages
Story timeline
Continue with this story
A short sequence of events and follow-up stories to understand the arc quickly.
How reliable this looks
Signal and trust for Ars Technica
This source works at a rapid pace: 100% of recent stories land in the hot window, and 0% carry visible search signal.
Reliability
92
Freshness
100
Sources in storyline
1
Related articles
More stories that share tags, source, or category context.
Report: SpaceX IPO gives Musk unchecked power and forbids investor lawsuits
Anyone who buys into SpaceX IPO must waive right to sue the firm, report says.
Signal weather
Momentum is building quickly, so this card is a good early entry point into the topic.
Why now
Fresh coverage with immediate momentum.
The animated version of the iconic "Hello, world" image reveals striking new details
What's going on with those satellites, anyway?
Signal weather
Momentum is building quickly, so this card is a good early entry point into the topic.
Why now
Fresh coverage with immediate momentum.
Google's Gemma 4 AI models get 3x speed boost by predicting future tokens
Up to 3x the speed with no loss of quality—is it too good to be true?
Signal weather
Momentum is building quickly, so this card is a good early entry point into the topic.
Why now
Fresh coverage with immediate momentum.
Here's what has to happen if NASA wants to land on the Moon every month
NASA is serious about taking more shots on goal, but some of them need to start landing.
Signal weather
Momentum is building quickly, so this card is a good early entry point into the topic.
Why now
Fresh coverage with immediate momentum.
More from Ars Technica
Fresh reporting and follow-up coverage from the same newsroom.
Report: SpaceX IPO gives Musk unchecked power and forbids investor lawsuits
Anyone who buys into SpaceX IPO must waive right to sue the firm, report says.
Signal weather
Momentum is building quickly, so this card is a good early entry point into the topic.
Why now
Fresh coverage with immediate momentum.
Google DeepMind partners with EVE Online for AI model testing
Move comes as CCP Games spends $120M to go independent, rebrands as Fenris Creations.
Signal weather
Momentum is building quickly, so this card is a good early entry point into the topic.
Why now
Fresh coverage with immediate momentum.
The animated version of the iconic "Hello, world" image reveals striking new details
What's going on with those satellites, anyway?
Signal weather
Momentum is building quickly, so this card is a good early entry point into the topic.
Why now
Fresh coverage with immediate momentum.
Anthropic's Claude Managed Agents can now "dream," sort of
Also, 5-hour usage limits will double for Pro and Max users of Claude Code.
Signal weather
Momentum is building quickly, so this card is a good early entry point into the topic.
Why now
Fresh coverage with immediate momentum.